Scleroderma clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
- PET Image in PAH Patients
- Evolution of the Chicago Classification: Bridging Physiology and Mechanics
- Scleroderma Registry & Repository at the Hospital for Special Surgery
- Deciphering the Genetic Architecture of Autoimmune Diseases
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- Rheumatology Diet Study
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Delving Into Participation Trends of Scleroderma Clinical Trials
- UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
- Comparative Autoantibody and Immunologic Cell Marker Study
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Scleroderma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.